Wadsak W, Mitterhauser M (March 2010). "Basics and principles of radiopharmaceuticals for PET/CT". European Journal of Radiology. 73 (3): 461–469. doi:10.1016/j.ejrad.2009.12.022. PMID20181453.
Jerabek PA, Patrick TB, Kilbourn MR, Dischino DD, Welch MJ (1986). "Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue". International Journal of Radiation Applications and Instrumentation, Part A. 37 (7): 599–605. doi:10.1016/0883-2889(86)90079-1. PMID3021662.
Tamaki N, Hirata K (August 2016). "Tumor hypoxia: a new PET imaging biomarker in clinical oncology". International Journal of Clinical Oncology. 21 (4): 619–625. doi:10.1007/s10147-015-0920-6. PMID26577447. S2CID30098261.
Zschaeck S, Löck S, Hofheinz F, Zips D, Saksø Mortensen L, Zöphel K, et al. (August 2020). "Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy". Radiotherapy and Oncology. 149: 189–196. doi:10.1016/j.radonc.2020.05.022. PMID32417350. S2CID218678537.
Wadsak W, Mitterhauser M (March 2010). "Basics and principles of radiopharmaceuticals for PET/CT". European Journal of Radiology. 73 (3): 461–469. doi:10.1016/j.ejrad.2009.12.022. PMID20181453.
Jerabek PA, Patrick TB, Kilbourn MR, Dischino DD, Welch MJ (1986). "Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue". International Journal of Radiation Applications and Instrumentation, Part A. 37 (7): 599–605. doi:10.1016/0883-2889(86)90079-1. PMID3021662.
Grunbaum Z, Freauff SJ, Krohn KA, Wilbur DS, Magee S, Rasey JS (January 1987). "Synthesis and characterization of congeners of misonidazole for imaging hypoxia". Journal of Nuclear Medicine. 28 (1): 68–75. PMID3794812.
Tamaki N, Hirata K (August 2016). "Tumor hypoxia: a new PET imaging biomarker in clinical oncology". International Journal of Clinical Oncology. 21 (4): 619–625. doi:10.1007/s10147-015-0920-6. PMID26577447. S2CID30098261.
Zschaeck S, Löck S, Hofheinz F, Zips D, Saksø Mortensen L, Zöphel K, et al. (August 2020). "Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy". Radiotherapy and Oncology. 149: 189–196. doi:10.1016/j.radonc.2020.05.022. PMID32417350. S2CID218678537.
Tamaki N, Hirata K (August 2016). "Tumor hypoxia: a new PET imaging biomarker in clinical oncology". International Journal of Clinical Oncology. 21 (4): 619–625. doi:10.1007/s10147-015-0920-6. PMID26577447. S2CID30098261.
Zschaeck S, Löck S, Hofheinz F, Zips D, Saksø Mortensen L, Zöphel K, et al. (August 2020). "Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy". Radiotherapy and Oncology. 149: 189–196. doi:10.1016/j.radonc.2020.05.022. PMID32417350. S2CID218678537.